Muthui Michelle K, Mogeni Polycarp, Mwai Kennedy, Nyundo Christopher, Macharia Alex, Williams Thomas N, Nyangweso George, Wambua Juliana, Mwanga Daniel, Marsh Kevin, Bejon Philip, Kapulu Melissa C
Department of Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, 230-80108, Kenya.
African Health Research Institute, Durban, Congella, 4013, Private bag X7, South Africa.
Wellcome Open Res. 2019 May 28;4:66. doi: 10.12688/wellcomeopenres.15186.2. eCollection 2019.
Interventions to block malaria transmission from humans to mosquitoes are currently in development. To be successfully implemented, key populations need to be identified where the use of these transmission-blocking and/or reducing strategies will have greatest impact. We used data from a longitudinally monitored cohort of children from Kilifi county located along the Kenyan coast collected between 1998-2016 to describe the distribution and prevalence of gametocytaemia in relation to transmission intensity, time and age. Data from 2,223 children accounting for 9,134 person-years of follow-up assessed during cross-sectional surveys for asexual parasites and gametocytes were used in logistic regression models to identify factors predictive of gametocyte carriage in this cohort. Our analysis showed that children 1-5 years of age were more likely to carry microscopically detectable gametocytes than their older counterparts. Carrying asexual parasites and recent episodes of clinical malaria were also strong predictors of gametocyte carriage. The prevalence of asexual parasites and of gametocyte carriage declined over time, and after 2006, when artemisinin combination therapy (ACT) was introduced, recent episodes of clinical malaria ceased to be a predictor of gametocyte carriage. Gametocyte carriage in children in Kilifi has fallen over time. Previous episodes of clinical malaria may contribute to the development of carriage, but this appears to be mitigated by the use of ACTs highlighting the impact that gametocidal antimalarials can have in reducing the overall prevalence of gametocytaemia when targeted on acute febrile illness.
目前正在研发阻断疟疾从人类传播至蚊子的干预措施。为了成功实施这些措施,需要确定关键人群,在这些人群中使用这些传播阻断和/或减少策略将产生最大影响。我们使用了1998年至2016年期间在肯尼亚沿海基利菲县纵向监测的儿童队列数据,以描述配子体血症的分布和流行情况与传播强度、时间和年龄的关系。在横断面调查中对无性寄生虫和配子体进行评估时,来自2223名儿童的数据(占9134人年的随访)被用于逻辑回归模型,以确定该队列中预测配子体携带的因素。我们的分析表明,1至5岁的儿童比年龄较大的儿童更有可能携带显微镜下可检测到的配子体。携带无性寄生虫和近期临床疟疾发作也是配子体携带的有力预测因素。无性寄生虫和配子体携带的患病率随时间下降,2006年引入青蒿素联合疗法(ACT)后,近期临床疟疾发作不再是配子体携带的预测因素。随着时间的推移,基利菲儿童的配子体携带率有所下降。先前的临床疟疾发作可能有助于携带的发展,但使用ACT似乎可以减轻这种情况,这突出了杀配子体抗疟药在针对急性发热疾病时对降低配子体血症总体患病率的影响。